Flax Pond Capital’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$553K Sell
17,688
-18,312
-51% -$859K 0.39% 49
2026
Q2
$1.93M Hold
36,000
– – 1.35% 28
2026
Q1
$1.74M Sell
36,000
-12,721
-26% -$871K 1.4% 26
2025
Q4
$3.39M Buy
+48,721
New +$1.99M 2.52% 19

Other funds holding GPCR

Flax Pond Capital's GPCR Position: Q3 2026 in Review

Flax Pond Capital reduced its Structure Therapeutics (GPCR) stake by 51% in Q3 2026, selling an estimated $859K and leaving 17,688 shares worth $553K. The position accounts for 0.39% of the portfolio, ranked #49.

Flax Pond Capital first reported a position in GPCR in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.39M in Q4 2025. 172 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • Flax Pond Capital held 17,688 shares of Structure Therapeutics worth $553K as of Q3 2026.
  • Flax Pond Capital sold 18,312 Structure Therapeutics shares in Q3 2026, an estimated $859K.
  • Structure Therapeutics made up 0.39% of Flax Pond Capital's portfolio in Q3 2026, its #49 holding.
  • Flax Pond Capital first reported a position in Structure Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Flax Pond Capital's Structure Therapeutics position peaked at $3.39M in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Flax Pond Capital's 13F filing for Q3 2026, filed 18 Nov 2026.